Vascular factors and mitochondrial dysfunction: A central role in the pathogenesis of alzheimer's disease

Current Neurovascular Research

Volumn 10, Issue 1, 2013, Pages 76-80

  Orsucci, Daniele ^a   Mancuso, Michelangelo ^a   Ienco, Elena Caldarazzo ^a   Simoncini, Costanza ^a   Siciliano, Gabriele ^a   Bonuccelli, Ubaldo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer disease; Ischemia; Mitochondria; MtDNA; Neurodegeneration; Oxidative stress; ROS

Indexed keywords

APOLIPOPROTEIN E; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANAEROBIC METABOLISM; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; BRAIN PERFUSION; CAPILLARY DENSITY; CELL INCLUSION; CITRIC ACID CYCLE; CYTOCHROME C OXIDASE DEFICIENCY; DECARBOXYLATION; DISEASE PREDISPOSITION; DNA DAMAGE; ENERGY METABOLISM; ENTORHINAL CORTEX; GLUCOSE METABOLISM; GLYCOLYSIS; HIPPOCAMPAL CA1 REGION; HUMAN; LIPID PEROXIDATION; METABOLISM; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POSTERIOR CINGULATE; PRIORITY JOURNAL; RISK FACTOR;

EID: 84873033865     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720213804805972     Document Type: Article

References (30)

1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81(2): 741-66.
2. Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13(11): 1359-62.
3. Mancuso M, Calsolaro V, Orsucci D, Siciliano G, Murri L. Is there a primary role of the mitochondrial genome in Alzheimer's disease? J Bioenerg Biomembr 2009; 41(5): 411-6.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297(5580): 353-6.
5. Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alzheimer Res 2009; 6(3): 224-37.
6. Carter CJ. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem Int 2007; 50(1): 12-38.
7. Zhu X, Smith MA, Honda K, et al. Vascular oxidative stress in Alzheimer disease. J Neurol Sci 2007; 257(1-2): 240-6.
8. Trimmer PA, Borland MK. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid Redox Signal 2005; 7(9-10): 1101-9.
9. Baloyannis SJ. Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 2006; 9(2): 119-26.
10. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 2005; 57(5): 695-703.
11. Liang WS, Reiman EM, Valla J, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 2008; 105(11): 4441-6.
12. Lynn BC, Wang J, Markesbery WR, Lovell MA. Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease. J Alzheimers Dis 2010; 19(1): 325-39.
13. Bosetti F, Brizzi F, Barogi S, et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002; 23(3): 371-6.
14. Mancuso M, Filosto M, Bosetti F, et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 2003; 182(2): 421-6.
15. Keller JN, Schmitt FA, Scheff SW, et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005; 64(7): 1152-6.
16. Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006; 96(3): 825-32.
17. Migliore L, Fontana I, Trippi F, et al. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 2005; 26(5): 567-73.
18. Isobe C, Abe T, Terayama Y. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients. Dement Geriatr Cogn Disord 2009; 28(5): 449-54.
19. Fukui H, Diaz F, Garcia S, Moraes CT. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2007; 104(35): 14163-8.
20. Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 2009; 218(2): 286- 92.
21. Sultana R, Perluigi M, Butterfield DA. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol 2009; 118(1): 131-50.
22. Du H, Guo L, Yan S, et al. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 2010; 107(43): 18670-5.
23. Mancardi GL, Perdelli F, Rivano C, Leonardi A, Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol 1980; 49(1): 79-83.
24. Perry G, Smith MA, McCann CE, et al. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res 1998; 791(1- 2): 63-6.
25. Tian J, Shi J, Bailey K, Mann DM. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 2004; 30(1): 46-56.
26. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35(11 Suppl 1): 2623-7.
27. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999; 19(6): 1959-64.
28. Nunomura A, Chiba S, Lippa CF, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 2004; 17(1): 108-13.
29. Aliyev A, Chen SG, Seyidova D, et al. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci 2005; 229-230: 285-92.
30. Hudson G, Sims R, Harold D, et al. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 2012; 78(14): 1038-42.